GE HealthCare (Nasdaq: GEHC) today announced an organizational change aimed at improving agility and addressing future ...

DeepQure announced today that it received FDA investigational device exemption (IDE) approval for a study of its HyperQure ...

The Duo tricuspid valve repair device. [Image courtesy of CroíValve] CroíValve today announced favorable patient outcomes in ...

Abbott’s MitraClip (left) and TriClip (right) devices. [Images from Abbott] Abbott (NYSE: ABT) + shared new data reinforcing ...

Cala announced today that it picked a new CEO as its TAPS therapy for essential tremor (ET) received Medicare coverage. The ...

ResMed (NYSE: RMD) announced data from a number of clinical studies demonstrating the benefits of positive airway pressure (PAP) therapy.

[Image from the Amber Therapeutics website] Amber Therapeutics announced today that it closed a Series A financing totaling $100 million to support its neuromodulation therapy. London-based Amber ...

Intuitive (NASDAQ: ISRG) announced today that the FDA cleared a labeling revision for its da Vinci X and Xi surgical robotic ...

LivaNova (NASDAQ: LIVN) announced that a study of its VNS Therapy for treatment-resistant depression failed to meet its ...

Asensus Surgical announced today that agreed to a deal in which Karl Storz will acquire it for 35¢ per share in cash.

Moon Surgical announced today that it received FDA clearance for the commercial version of its Maestro surgical robot system.

Edwards Lifesciences (NYSE: EW) today announced data supporting the use of its transcatheter aortic valve replacement (TAVR) ...